25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Compugen
Buy, Hold or Sell?

Let's analyze Compugen together

I guess you are interested in Compugen. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Compugen. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Compugen

I send you an email if I find something interesting about Compugen.

1. Quick Overview

1.1. Quick analysis of Compugen (30 sec.)










1.2. What can you expect buying and holding a share of Compugen? (30 sec.)

How much money do you get?

How much money do you get?
ILA0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
ILA274.83
Expected worth in 1 year
ILA71.58
How sure are you?
40.0%

+ What do you gain per year?

Total Gains per Share
ILA-203.25
Return On Investment
-30.9%

For what price can you sell your share?

Current Price per Share
ILA657.60
Expected price per share
ILA577.50 - ILA761.60
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Compugen (5 min.)




Live pricePrice per Share (EOD)
ILA657.60
Intrinsic Value Per Share
ILA-1,668.35 - ILA-1,551.64
Total Value Per Share
ILA-1,393.53 - ILA-1,276.82

2.2. Growth of Compugen (5 min.)




Is Compugen growing?

Current yearPrevious yearGrowGrow %
How rich?$65.4m$77.5m-$12.1m-18.5%

How much money is Compugen making?

Current yearPrevious yearGrowGrow %
Making money-$18.7m-$33.6m$14.9m79.7%
Net Profit Margin-56.1%-449.3%--

How much money comes from the company's main activities?

2.3. Financial Health of Compugen (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#425 / 961

Most Revenue
#178 / 961

Most Profit
#668 / 961

Most Efficient
#424 / 961
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Compugen?

Welcome investor! Compugen's management wants to use your money to grow the business. In return you get a share of Compugen.

First you should know what it really means to hold a share of Compugen. And how you can make/lose money.

Speculation

The Price per Share of Compugen is ILA657.60. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Compugen.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Compugen, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ILA274.83. Based on the TTM, the Book Value Change Per Share is ILA-50.81 per quarter. Based on the YOY, the Book Value Change Per Share is ILA-121.62 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ILA0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Compugen.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ILA% of Price per ShareILA% of Price per ShareILA% of Price per ShareILA% of Price per ShareILA% of Price per Share
Usd Eps-0.210.0%-0.210.0%-0.38-0.1%-0.320.0%-0.300.0%
Usd Book Value Change Per Share-0.140.0%-0.140.0%-0.320.0%0.060.0%0.040.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.140.0%-0.140.0%-0.320.0%0.060.0%0.040.0%
Usd Price Per Share1.83-1.83-0.64-4.39-4.69-
Price to Earnings Ratio-8.75--8.75--1.71--13.85--19.75-
Price-to-Total Gains Ratio-13.54--13.54--1.99-86.18-40.69-
Price to Book Ratio2.50-2.50-0.74-5.39-6.06-
Price-to-Total Gains Ratio-13.54--13.54--1.99-86.18-40.69-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.749216
Number of shares571
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.140.06
Usd Total Gains Per Share-0.140.06
Gains per Quarter (571 shares)-77.1836.06
Gains per Year (571 shares)-308.70144.23
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-309-3190144134
20-617-6280288278
30-926-9370433422
40-1235-12460577566
50-1544-15550721710
60-1852-18640865854
70-2161-217301010998
80-2470-2482011541142
90-2778-2791012981286
100-3087-3100014421430

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%0.011.00.00.0%
Book Value Change Per Share0.01.00.00.0%0.03.00.00.0%2.03.00.040.0%4.06.00.040.0%5.06.00.045.5%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%0.00.011.00.0%
Total Gains per Share0.01.00.00.0%0.03.00.00.0%2.03.00.040.0%4.06.00.040.0%5.06.00.045.5%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Compugen compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---50.812-50.8120%-121.624+139%23.740-314%14.115-460%
Book Value Per Share--274.826274.8260%325.638-16%342.100-20%307.740-11%
Current Ratio--4.3624.3620%7.226-40%7.532-42%8.526-49%
Debt To Asset Ratio--0.4600.4600%0.175+162%0.250+84%0.207+122%
Debt To Equity Ratio--0.8510.8510%0.212+301%0.372+129%0.292+192%
Dividend Per Share----0%-0%-0%-0%
Eps---78.617-78.6170%-141.247+80%-120.467+53%-111.556+42%
Free Cash Flow Per Share---151.157-151.1570%-146.692-3%-126.283-16%-116.846-23%
Free Cash Flow To Equity Per Share---138.241-138.2410%-145.212+5%3.391-4177%-7.097-95%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---1551.645--------
Intrinsic Value_10Y_min---1668.351--------
Intrinsic Value_1Y_max---132.877--------
Intrinsic Value_1Y_min---141.921--------
Intrinsic Value_3Y_max---416.472--------
Intrinsic Value_3Y_min---450.819--------
Intrinsic Value_5Y_max---720.844--------
Intrinsic Value_5Y_min---784.095--------
Market Cap58879136640.000-5%61601043200.00061601043200.0000%21676762440.000+184%147647314328.000-58%157777462624.000-61%
Net Profit Margin---0.561-0.5610%-4.493+702%-5.121+814%-7.419+1224%
Operating Margin----0%-4.7170%-5.2620%-7.4550%
Operating Ratio--1.4481.4480%5.847-75%6.206-77%8.617-83%
Pb Ratio2.393-5%2.5032.5030%0.743+237%5.386-54%6.062-59%
Pe Ratio-8.365+4%-8.751-8.7510%-1.714-80%-13.849+58%-19.747+126%
Price Per Share657.600-5%688.000688.0000%242.100+184%1649.020-58%1762.160-61%
Price To Free Cash Flow Ratio-4.350+4%-4.552-4.5520%-1.650-64%-14.077+209%-9.209+102%
Price To Total Gains Ratio-12.942+4%-13.540-13.5400%-1.991-85%86.176-116%40.693-133%
Quick Ratio--3.7233.7230%6.072-39%6.492-43%6.652-44%
Return On Assets---0.155-0.1550%-0.358+131%-0.299+93%-0.362+134%
Return On Equity---0.286-0.2860%-0.434+52%-0.400+40%-0.470+64%
Total Gains Per Share---50.812-50.8120%-121.624+139%23.740-314%14.115-460%
Usd Book Value--65454394.06065454394.0600%77556053.792-16%81476787.871-20%73293565.887-11%
Usd Book Value Change Per Share---0.135-0.1350%-0.324+139%0.063-314%0.038-460%
Usd Book Value Per Share--0.7310.7310%0.866-16%0.910-20%0.819-11%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.209-0.2090%-0.376+80%-0.320+53%-0.297+42%
Usd Free Cash Flow---36000465.855-36000465.8550%-34937165.169-3%-30076333.507-16%-19480267.610-46%
Usd Free Cash Flow Per Share---0.402-0.4020%-0.390-3%-0.336-16%-0.311-23%
Usd Free Cash Flow To Equity Per Share---0.368-0.3680%-0.386+5%0.009-4177%-0.019-95%
Usd Market Cap156618503.462-5%163858774.912163858774.9120%57660188.090+184%392741856.112-58%419688050.580-61%
Usd Price Per Share1.749-5%1.8301.8300%0.644+184%4.386-58%4.687-61%
Usd Profit---18724076.118-18724076.1180%-33640237.854+80%-28691346.924+53%-26568938.850+42%
Usd Revenue--33405612.82033405612.8200%7488033.000+346%9776176.204+242%8897280.811+275%
Usd Total Gains Per Share---0.135-0.1350%-0.324+139%0.063-314%0.038-460%
 EOD+3 -5MRQTTM+0 -0YOY+19 -135Y+10 -2210Y+10 -22

3.3 Fundamental Score

Let's check the fundamental score of Compugen based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-8.365
Price to Book Ratio (EOD)Between0-12.393
Net Profit Margin (MRQ)Greater than0-0.561
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than13.723
Current Ratio (MRQ)Greater than14.362
Debt to Asset Ratio (MRQ)Less than10.460
Debt to Equity Ratio (MRQ)Less than10.851
Return on Equity (MRQ)Greater than0.15-0.286
Return on Assets (MRQ)Greater than0.05-0.155
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Compugen based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5042.013
Ma 20Greater thanMa 50696.175
Ma 50Greater thanMa 100690.654
Ma 100Greater thanMa 200707.408
OpenGreater thanClose684.100
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About Compugen

Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tumors; COM902, a therapeutic antibody targeting TIGIT, which is in Phase I monotherapy clinical study in patients with advanced malignancies through sequential dose escalations; Bapotulimab, a therapeutic antibody targeting ILDR2 that is in Phase I clinical study in patients with naïve head and neck squamous cell carcinoma; and Rilvegostomig, a novel anti-TIGIT/PD-1 bispecific antibody, which is in Phase II clinical study in patients with advanced or metastatic non-small cell lung cancer. Its therapeutic pipeline also includes early-stage immuno-oncology programs focused to address various mechanisms of immune resistance; and COM503, high affinity antibody, which blocks the interaction between IL-18 binding protein and IL-18. The company has collaboration agreement with Bayer Pharma AG for the research, development, and commercialization of antibody-based therapeutics against the company's immune checkpoint regulators; Bristol-Myers Squibb to evaluate the safety and tolerability of COM701 in combination with Bristol-Myers Squibb's PD-1 immune checkpoint inhibitor Opdivo in patients with advanced solid tumors; and Johns Hopkins School of Medicine to evaluate novel T cell and myeloid checkpoint targets. It has license agreement with AstraZeneca for the development of bi-specific and multi-specific immuno-oncology antibody products; and research collaboration with Johns Hopkins University for myeloid. Compugen Ltd. was incorporated in 1993 and is headquartered in Holon, Israel.

Fundamental data was last updated by Penke on 2024-10-03 03:37:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Compugen earns for each 1 of revenue.

  • Above 10% is considered healthy but always compare Compugen to the Biotechnology industry mean.
  • A Net Profit Margin of -56.1% means that -0.56 for each 1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Compugen:

  • The MRQ is -56.1%. The company is making a huge loss. -2
  • The TTM is -56.1%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-56.1%TTM-56.1%0.0%
TTM-56.1%YOY-449.3%+393.2%
TTM-56.1%5Y-512.1%+456.0%
5Y-512.1%10Y-741.9%+229.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-56.1%-115.9%+59.8%
TTM-56.1%-189.7%+133.6%
YOY-449.3%-205.7%-243.6%
5Y-512.1%-363.4%-148.7%
10Y-741.9%-469.8%-272.1%
4.3.1.2. Return on Assets

Shows how efficient Compugen is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Compugen to the Biotechnology industry mean.
  • -15.5% Return on Assets means that Compugen generated -0.15 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Compugen:

  • The MRQ is -15.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -15.5%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-15.5%TTM-15.5%0.0%
TTM-15.5%YOY-35.8%+20.3%
TTM-15.5%5Y-29.9%+14.4%
5Y-29.9%10Y-36.2%+6.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-15.5%-10.9%-4.6%
TTM-15.5%-11.7%-3.8%
YOY-35.8%-11.2%-24.6%
5Y-29.9%-12.9%-17.0%
10Y-36.2%-14.4%-21.8%
4.3.1.3. Return on Equity

Shows how efficient Compugen is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Compugen to the Biotechnology industry mean.
  • -28.6% Return on Equity means Compugen generated -0.29 for each 1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Compugen:

  • The MRQ is -28.6%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -28.6%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-28.6%TTM-28.6%0.0%
TTM-28.6%YOY-43.4%+14.8%
TTM-28.6%5Y-40.0%+11.4%
5Y-40.0%10Y-47.0%+7.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-28.6%-14.1%-14.5%
TTM-28.6%-15.9%-12.7%
YOY-43.4%-13.6%-29.8%
5Y-40.0%-19.0%-21.0%
10Y-47.0%-19.3%-27.7%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Compugen.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Compugen is operating .

  • Measures how much profit Compugen makes for each 1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Compugen to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated 0.00  for each 1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Compugen:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-471.7%+471.7%
TTM-5Y-526.2%+526.2%
5Y-526.2%10Y-745.5%+219.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--258.6%+258.6%
TTM--292.1%+292.1%
YOY-471.7%-222.0%-249.7%
5Y-526.2%-385.5%-140.7%
10Y-745.5%-497.6%-247.9%
4.3.2.2. Operating Ratio

Measures how efficient Compugen is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.45 means that the operating costs are 1.45 for each 1 in net sales.

Let's take a look of the Operating Ratio trends of Compugen:

  • The MRQ is 1.448. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.448. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.448TTM1.4480.000
TTM1.448YOY5.847-4.398
TTM1.4485Y6.206-4.758
5Y6.20610Y8.617-2.411
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4482.649-1.201
TTM1.4483.101-1.653
YOY5.8473.298+2.549
5Y6.2065.011+1.195
10Y8.6176.530+2.087
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Compugen.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Compugen is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 4.36 means the company has 4.36 in assets for each 1 in short-term debts.

Let's take a look of the Current Ratio trends of Compugen:

  • The MRQ is 4.362. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.362. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.362TTM4.3620.000
TTM4.362YOY7.226-2.864
TTM4.3625Y7.532-3.170
5Y7.53210Y8.526-0.993
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.3623.793+0.569
TTM4.3624.010+0.352
YOY7.2264.740+2.486
5Y7.5325.980+1.552
10Y8.5266.318+2.208
4.4.3.2. Quick Ratio

Measures if Compugen is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Compugen to the Biotechnology industry mean.
  • A Quick Ratio of 3.72 means the company can pay off 3.72 for each 1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Compugen:

  • The MRQ is 3.723. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 3.723. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ3.723TTM3.7230.000
TTM3.723YOY6.072-2.349
TTM3.7235Y6.492-2.768
5Y6.49210Y6.652-0.160
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.7233.349+0.374
TTM3.7233.580+0.143
YOY6.0724.735+1.337
5Y6.4925.922+0.570
10Y6.6526.499+0.153
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Compugen.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Compugen assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Compugen to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.46 means that Compugen assets are financed with 46.0% credit (debt) and the remaining percentage (100% - 46.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Compugen:

  • The MRQ is 0.460. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.460. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.460TTM0.4600.000
TTM0.460YOY0.175+0.285
TTM0.4605Y0.250+0.210
5Y0.25010Y0.207+0.043
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4600.340+0.120
TTM0.4600.341+0.119
YOY0.1750.309-0.134
5Y0.2500.365-0.115
10Y0.2070.382-0.175
4.5.4.2. Debt to Equity Ratio

Measures if Compugen is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Compugen to the Biotechnology industry mean.
  • A Debt to Equity ratio of 85.1% means that company has 0.85 debt for each 1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Compugen:

  • The MRQ is 0.851. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.851. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.851TTM0.8510.000
TTM0.851YOY0.212+0.638
TTM0.8515Y0.372+0.479
5Y0.37210Y0.292+0.080
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8510.393+0.458
TTM0.8510.437+0.414
YOY0.2120.373-0.161
5Y0.3720.449-0.077
10Y0.2920.489-0.197
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every 1 in earnings Compugen generates.

  • Above 15 is considered overpriced but always compare Compugen to the Biotechnology industry mean.
  • A PE ratio of -8.75 means the investor is paying -8.75 for every 1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Compugen:

  • The EOD is -8.365. Based on the earnings, the company is expensive. -2
  • The MRQ is -8.751. Based on the earnings, the company is expensive. -2
  • The TTM is -8.751. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-8.365MRQ-8.751+0.387
MRQ-8.751TTM-8.7510.000
TTM-8.751YOY-1.714-7.037
TTM-8.7515Y-13.849+5.098
5Y-13.84910Y-19.747+5.897
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-8.365-2.319-6.046
MRQ-8.751-2.392-6.359
TTM-8.751-2.926-5.825
YOY-1.714-3.428+1.714
5Y-13.849-5.926-7.923
10Y-19.747-6.207-13.540
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Compugen:

  • The EOD is -4.350. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -4.552. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -4.552. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-4.350MRQ-4.552+0.201
MRQ-4.552TTM-4.5520.000
TTM-4.552YOY-1.650-2.901
TTM-4.5525Y-14.077+9.525
5Y-14.07710Y-9.209-4.868
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-4.350-2.989-1.361
MRQ-4.552-3.184-1.368
TTM-4.552-3.470-1.082
YOY-1.650-4.583+2.933
5Y-14.077-8.064-6.013
10Y-9.209-8.680-0.529
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Compugen is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 2.50 means the investor is paying 2.50 for each 1 in book value.

Let's take a look of the Price to Book Ratio trends of Compugen:

  • The EOD is 2.393. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.503. Based on the equity, the company is underpriced. +1
  • The TTM is 2.503. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.393MRQ2.503-0.111
MRQ2.503TTM2.5030.000
TTM2.503YOY0.743+1.760
TTM2.5035Y5.386-2.883
5Y5.38610Y6.062-0.675
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD2.3931.968+0.425
MRQ2.5031.972+0.531
TTM2.5032.204+0.299
YOY0.7432.370-1.627
5Y5.3863.574+1.812
10Y6.0624.216+1.846
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets121,334
Total Liabilities55,775
Total Stockholder Equity65,559
 As reported
Total Liabilities 55,775
Total Stockholder Equity+ 65,559
Total Assets = 121,334

Assets

Total Assets121,334
Total Current Assets114,579
Long-term Assets6,755
Total Current Assets
Cash And Cash Equivalents 13,890
Short-term Investments 36,795
Net Receivables 61,000
Total Current Assets  (as reported)114,579
Total Current Assets  (calculated)111,685
+/- 2,894
Long-term Assets
Property Plant Equipment 2,545
Long-term Assets  (as reported)6,755
Long-term Assets  (calculated)2,545
+/- 4,210

Liabilities & Shareholders' Equity

Total Current Liabilities26,266
Long-term Liabilities29,509
Total Stockholder Equity65,559
Total Current Liabilities
Accounts payable 3,502
Total Current Liabilities  (as reported)26,266
Total Current Liabilities  (calculated)3,502
+/- 22,764
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt1,351
Long-term Liabilities  (as reported)29,509
Long-term Liabilities  (calculated)1,351
+/- 28,158
Total Stockholder Equity
Total Stockholder Equity (as reported)65,559
Total Stockholder Equity (calculated)0
+/- 65,559
Other
Capital Stock247
Common Stock Shares Outstanding 89,237
Net Invested Capital 65,559
Net Working Capital 88,313
Property Plant and Equipment Gross 7,901



6.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
> Total Assets 
56,711
114,986
99,307
71,139
38,746
53,180
53,763
138,316
132,163
94,176
121,334
121,33494,176132,163138,31653,76353,18038,74671,13999,307114,98656,711
   > Total Current Assets 
53,216
75,098
90,999
62,680
31,179
46,578
45,000
129,090
123,222
86,125
114,579
114,57986,125123,222129,09045,00046,57831,17962,68090,99975,09853,216
       Cash And Cash Equivalents 
28,751
25,643
10,777
9,709
25,470
5,861
9,187
7,143
7,801
11,059
13,890
13,89011,0597,8017,1439,1875,86125,4709,70910,77725,64328,751
       Short-term Investments 
22,580
48,196
69,993
50,825
3,918
39,209
34,040
116,622
109,248
72,287
36,795
36,79572,287109,248116,62234,04039,2093,91850,82569,99348,19622,580
       Net Receivables 
1,229
58
8,311
75
34
109
35
2,000
57
85
61,000
61,00085572,0003510934758,311581,229
       Other Current Assets 
154
684
1,077
1,000
1,067
605
652
667
713
362
0
03627136676526051,0671,0001,077684154
   > Long-term Assets 
0
0
0
8,459
7,567
6,602
8,763
9,226
8,941
8,051
6,755
6,7558,0518,9419,2268,7636,6027,5678,459000
       Property Plant Equipment 
1,208
2,730
6,028
5,965
4,647
3,372
5,585
4,483
3,905
3,358
2,545
2,5453,3583,9054,4835,5853,3724,6475,9656,0282,7301,208
       Long Term Investments 
0
35,026
2,179
2,402
2,810
0
0
0
0
0
0
0000002,8102,4022,17935,0260
       Long-term Assets Other 
0
0
0
8,459
7,567
6,602
8,763
0
0
0
0
00008,7636,6027,5678,459000
> Total Liabilities 
24,823
8,870
9,410
7,620
9,449
15,937
15,442
18,534
25,470
16,496
55,775
55,77516,49625,47018,53415,44215,9379,4497,6209,4108,87024,823
   > Total Current Liabilities 
7,739
6,589
6,854
4,740
6,194
9,989
6,819
10,523
17,096
11,919
26,266
26,26611,91917,09610,5236,8199,9896,1944,7406,8546,5897,739
       Accounts payable 
693
1,493
2,001
1,274
3,445
2,946
1,088
1,413
4,621
1,773
3,502
3,5021,7734,6211,4131,0882,9463,4451,2742,0011,493693
       Other Current Liabilities 
5,323
2,517
1,687
4
0
1,089
774
668
3,629
325
0
03253,6296687741,089041,6872,5175,323
   > Long-term Liabilities 
0
0
0
2,880
3,255
5,948
8,623
8,011
8,374
4,577
29,509
29,5094,5778,3748,0118,6235,9483,2552,880000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
3,578
3,166
2,750
1,925
1,351
1,3511,9252,7503,1663,578000000
> Total Stockholder Equity
31,888
106,116
89,897
63,519
29,297
37,243
38,321
119,782
106,693
77,680
65,559
65,55977,680106,693119,78238,32137,24329,29763,51989,897106,11631,888
   Common Stock
111
137
138
140
140
164
187
231
239
240
0
0240239231187164140140138137111
   Retained Earnings Total Equity00000000000
   Accumulated Other Comprehensive Income 00000000000
   Capital Surplus 00000000000
   Treasury Stock00000000000
   Other Stockholders Equity 
4,628
1,222
421
7
17
0
0
0
0
0
0
0000001774211,2224,628



6.3. Balance Sheets

Currency in USD. All numbers in thousands.




6.4. Cash Flows

Currency in USD. All numbers in thousands.




6.5. Income Statements

Currency in USD. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue33,459
Cost of Revenue-2,004
Gross Profit31,45531,455
 
Operating Income (+$)
Gross Profit31,455
Operating Expense-46,451
Operating Income-12,992-14,996
 
Operating Expense (+$)
Research Development34,472
Selling General Administrative9,975
Selling And Marketing Expenses-
Operating Expense46,45144,447
 
Net Interest Income (+$)
Interest Income2,960
Interest Expense--
Other Finance Cost-250
Net Interest Income3,210
 
Pretax Income (+$)
Operating Income-12,992
Net Interest Income3,210
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-9,784-12,990
EBIT - interestExpense = 0
-18,754
-18,754
Interest Expense-
Earnings Before Interest and Taxes (EBIT)--9,784
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-9,784
Tax Provision-8,970
Net Income From Continuing Ops-18,754-18,754
Net Income-18,754
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-2-3,210
 

Technical Analysis of Compugen
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Compugen. The general trend of Compugen is BEARISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Compugen's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-57.1%) Bearish trend (57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Compugen.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 682.60 < 754.70 < 761.60.

The bearish price targets are: 645.10 > 606.10 > 577.50.

Tweet this
Compugen Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Compugen. The current mas is .

The long score for the Moving Averages is 3/14.
The longshort score for the Moving Averages is -8/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Compugen Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Compugen. The current macd is -10.38484641.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Compugen price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Compugen. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Compugen price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Compugen Daily Moving Average Convergence/Divergence (MACD) ChartCompugen Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Compugen. The current adx is 14.08.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Compugen shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Compugen Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Compugen. The current sar is 690.00.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Compugen Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Compugen. The current rsi is 42.01. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Compugen Daily Relative Strength Index (RSI) ChartCompugen Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Compugen. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Compugen price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Compugen Daily Stochastic Oscillator ChartCompugen Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Compugen. The current cci is -84.89146068.

Compugen Daily Commodity Channel Index (CCI) ChartCompugen Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Compugen. The current cmo is -23.03647374.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Compugen Daily Chande Momentum Oscillator (CMO) ChartCompugen Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Compugen. The current willr is -87.32251521.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Compugen Daily Williams %R ChartCompugen Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Compugen.

Compugen Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Compugen. The current atr is 25.20.

Compugen Daily Average True Range (ATR) ChartCompugen Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Compugen. The current obv is 5,058,326.

Compugen Daily On-Balance Volume (OBV) ChartCompugen Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Compugen. The current mfi is 20.64.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Compugen Daily Money Flow Index (MFI) ChartCompugen Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Compugen.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-05-16SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-05-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-05-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-05-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-05-22STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-05-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-05-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-28BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-05-30ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-02CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-06-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-06-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-13WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-06-19CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-06-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-25STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-06-26CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-06-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-03STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-07STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-08MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-07-09SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-15STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-18STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-21STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-23STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-25STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-07-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-07-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-31DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-01SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-08-04STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-08-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-07STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-08-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-18STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-08-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-22BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-27STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-01STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-04CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-05CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-10DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-16CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-09-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-24BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-09-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-08STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

Compugen Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Compugen based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5042.013
Ma 20Greater thanMa 50696.175
Ma 50Greater thanMa 100690.654
Ma 100Greater thanMa 200707.408
OpenGreater thanClose684.100
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Compugen with someone you think should read this too:
  • Are you bullish or bearish on Compugen? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Compugen? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Compugen

I send you an email if I find something interesting about Compugen.


Comments

How you think about this?

Leave a comment

Stay informed about Compugen.

Receive notifications about Compugen in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.